NCT06064539View on ClinicalTrials.gov

Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

July 8, 2020

Study Completion Date

July 8, 2020

Conditions
Multiple Sclerosis
Interventions
DRUG

Tolebrutinib

Tablet, taken orally

DRUG

gemfibrozil

Tablet, taken orally

DRUG

rifampicin

Tablet, taken orally

Trial Locations (1)

55144

Prism Research-Site Number:8400001, Saint Paul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY